Skip to Content

Pharmaceutical Sales 2009

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2009, listed by U.S. sales value and brand name.
Quarterly top 100 prescription sales data now available, from Q1 2011.

Top 200 Drugs for 2009 by Sales

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2008
1 Lipitor Pfizer Inc. 5,363,193 -8.8%
2 Nexium AstraZeneca 5,014,827 4.6%
3 Plavix Bristol-Myers Squibb Company 4,223,124 11.2%
4 Advair Diskus GlaxoSmithKline 3,653,410 2.3%
5 (1) Seroquel AstraZeneca 3,117,591 7.2%
6 (6) Abilify Bristol-Myers Squibb Company 3,083,351 30.0%
7 Singulair Merck 3,027,378 4.5%
8 (1) OxyContin Purdue Pharma LP 3,020,239 20.7%
9 (1) Actos Takeda Pharmaceuticals U.S.A., Inc. 2,531,621 3.4%
10 (5) Prevacid Takeda Pharmaceuticals U.S.A., Inc. 2,508,555 -23.9%
11 (3) Cymbalta Eli Lilly and Company 2,404,353 10.8%
12 (4) Effexor XR Pfizer Inc. 2,385,507 -10.2%
13 (2) Lexapro Actavis Pharma, Inc. 2,334,422 -3.2%
14 (3) Crestor AstraZeneca 2,308,138 37.7%
15 Zyprexa Eli Lilly and Company 1,855,436 6.1%
16 Valtrex GlaxoSmithKline 1,754,727 4.2%
17 (10) Flomax Boehringer Ingelheim Pharmaceuticals, Inc. 1,556,273 25.8%
18 (3) Lantus Sanofi 1,512,403 2.5%
19 (5) Lyrica Pfizer Inc. 1,445,445 4.0%
20 Celebrex Pfizer Inc. 1,437,539 -5.8%
21 (1) Levaquin Janssen Pharmaceuticals, Inc. 1,373,131 -6.0%
22 (9) Aricept Eisai Inc. 1,347,293 17.2%
23 (9) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. 1,338,252 17.1%
24 (1) Diovan Novartis Pharmaceuticals Corporation 1,328,515 3.5%
25 (4) Diovan HCT Novartis Pharmaceuticals Corporation 1,244,245 2.6%
26 Tricor Abbott Laboratories 1,224,894 -2.0%
27 (6) Concerta Janssen Pharmaceuticals, Inc. 1,180,887 7.0%
28 (13) Januvia Merck 1,145,933 25.4%
29 (11) Vytorin Merck 1,133,438 -26.7%
30 (7) Adderall XR Takeda Pharmaceuticals U.S.A., Inc. 1,130,274 -21.9%
31 (9) Lovenox Sanofi 1,075,620 17.7%
32 (7) Atripla Bristol-Myers Squibb Company 1,064,056 16.2%
33 (3) Zetia Merck 1,025,238 -13.4%
34 Aciphex Eisai Inc. 996,052 -5.3%
35 (8) Ambien CR Sanofi 983,296 13.6%
36 (2) Viagra Pfizer Inc. 974,727 5.9%
37 (24) Topamax Janssen Pharmaceuticals, Inc. 939,312 -55.9%
38 (2) Lidoderm Endo Pharmaceuticals Inc. 937,263 -3.4%
39 (33) ProAir HFA Teva Pharmaceuticals USA, Inc. 935,532 77.3%
40 () NovoLog Novo Nordisk 905,235 26.6%
41 (29) Suboxone Reckitt Benckiser Pharmaceuticals Inc. 894,208 68.1%
42 Nasonex Merck 893,579 -1.2%
43 (1) Provigil Cephalon, Inc. 883,339 4.4%
44 (1) Geodon Oral Pfizer Inc. 873,952 9.6%
45 (1) Truvada Gilead Sciences, Inc. 862,711 11.2%
46 (1) Lunesta Sepracor Inc. 813,087 5.5%
47 (4) Humalog Eli Lilly and Company 757,108 7.7%
48 (8) Niaspan Abbott Laboratories 716,589 12.2%
49 (3) Detrol LA Pfizer Inc. 711,749 2.1%
50 (11) Yaz Bayer HealthCare Pharmaceuticals Inc. 701,540 19.8%
51 (3) Cozaar Merck 697,815 1.1%
52 (11) Namenda Actavis Pharma, Inc. 670,226 15.1%
53 (43) Vyvanse Takeda Pharmaceuticals U.S.A., Inc. 660,109 76.0%
54 (68) Tamiflu Genentech, Inc. 651,444 136.8%
55 (11) Cialis Eli Lilly and Company 650,494 17.2%
56 (8) Arimidex AstraZeneca 640,326 12.6%
57 (9) Enbrel Amgen Inc. 638,695 -16.4%
58 (9) Flovent HFA GlaxoSmithKline 621,041 12.3%
59 (52) Lantus SoloStar Sanofi 610,161 93.1%
60 (5) Combivent Boehringer Ingelheim Pharmaceuticals, Inc. 608,121 8.9%
61 (6) Pulmicort Respules AstraZeneca 607,397 -6.7%
62 (2) Byetta Amylin Pharmaceuticals, Inc. 554,861 -6.7%
63 (11) Benicar HCT Daiichi Sankyo 553,640 7.5%
64 (24) AndroGel Abbott Laboratories 546,994 24.0%
65 (3) Prograf Astellas Pharma US, Inc. 541,151 -7.4%
66 (5) Hyzaar Merck 539,827 2.2%
67 (19) Benicar Daiichi Sankyo 526,569 15.6%
68 (1) Premarin tabs Pfizer Inc. 520,151 -5.2%
69 (18) Gleevec Novartis Pharmaceuticals Corporation 519,508 15.3%
70 (3) Reyataz Bristol-Myers Squibb Company 519,018 -0.1%
71 (6) Boniva Genentech, Inc. 511,277 -0.2%
72 (6) Strattera Eli Lilly and Company 511,187 -0.1%
73 (54) Lamictal GlaxoSmithKline 498,599 -67.6%
74 (1) Synthroid Abbott Laboratories 495,523 -3.8%
75 (7) Asacol Actavis Pharma, Inc. 491,311 5.9%
76 (63) Symbicort AstraZeneca 487,690 105.0%
77 (8) Humira Pen Abbott Laboratories 487,601 27.8%
78 (32) Solodyn Medicis Pharmaceutical Corporation 479,365 51.7%
79 (31) Enbrel Sureclick Amgen Inc. 479,132 10.5%
80 (22) Chantix Pfizer Inc. 472,207 -22.0%
81 (1) Skelaxin Elan Corporation plc 472,083 -5.8%
82 (32) CellCept Genentech, Inc. 468,229 -34.2%
83 (2) Evista Eli Lilly and Company 466,955 -6.6%
84 (16) Protonix Pfizer Inc. 461,079 -16.6%
85 (1) Xalatan Pfizer Inc. 457,121 0.2%
86 (37) Actonel Actavis Pharma, Inc. 435,977 -39.0%
87 (12) Copaxone Accredo Health Group, Inc. 428,384 15.6%
88 (13) Femara Novartis Pharmaceuticals Corporation 427,132 18.3%
89 (19) Mirapex Boehringer Ingelheim Pharmaceuticals, Inc. 417,934 24.6%
90 (10) Avodart GlaxoSmithKline 416,285 14.1%
91 (15) Avandia GlaxoSmithKline 407,906 -20.6%
92 (7) Humira Abbott Laboratories 402,654 -11.7%
93 (13) NovoLog Mix 70/30 Novo Nordisk 400,683 15.4%
94 Avapro Bristol-Myers Squibb Company 398,768 -1.7%
95 (12) Restasis Actavis Pharma, Inc. 398,143 17.4%
96 (31) Levemir Novo Nordisk 394,246 53.9%
97 (7) Avelox Bayer HealthCare Pharmaceuticals Inc. 388,933 -9.3%
98 (17) Vesicare Astellas Pharma US, Inc. 379,283 26.8%
99 (41) Janumet Merck 378,837 59.6%
100 (4) Sensipar Amgen Inc. 369,011 5.9%
101 (4) Aldara Medicis Pharmaceutical Corporation 366,825 5.5%
102 (4) Xopenex Akorn, Inc. 356,898 -4.1%
103 () Seroquel XR AstraZeneca 356,402 151.8%
104 (9) Focalin XR Novartis Pharmaceuticals Corporation 352,024 13.6%
105 (12) RenaGel Genzyme Corporation 351,383 -14.0%
106 (4) Avalide Bristol-Myers Squibb Company 350,462 -1.5%
107 (70) Keppra UCB, Inc. 339,978 -63.9%
108 (6) Actoplus Met Takeda Pharmaceuticals U.S.A., Inc. 338,930 12.5%
109 () Caduet Pfizer Inc. 331,382 -15.0%
110 () Lotrel Novartis Pharmaceuticals Corporation 323,873 -12.0%
111 (13) NuvaRing Merck 318,518 19.2%
112 Norvir Abbott Laboratories 311,949 0.2%
113 (16) Kaletra Abbott Laboratories 309,015 -17.2%
114 () Ventolin HFA GlaxoSmithKline 297,759 285.3%
115 (62) Isentress Merck 286,333 63.2%
116 (16) Invega Janssen Pharmaceuticals, Inc. 280,698 14.1%
117 () Prevacid SoluTab Takeda Pharmaceuticals U.S.A., Inc. 276,710 NA
118 (11) Risperdal Consta Janssen Pharmaceuticals, Inc. 274,523 9.4%
119 (66) Depakote ER Abbott Laboratories 272,177 -60.7%
120 (3) Avonex Biogen 271,515 -0.7%
121 (70) Doryx Actavis Pharma, Inc. 268,774 69.6%
122 (36) Loestrin 24 Fe Allergan plc 267,190 33.4%
123 (7) Forteo Eli Lilly and Company 266,923 -8.5%
124 () Pristiq Pfizer Inc. 266,654 397.5%
125 (1) Epzicom GlaxoSmithKline 260,282 -1.9%
126 (6) Tarceva Astellas Pharma US, Inc. 257,591 -7.0%
127 (16) Proventil HFA Merck 257,440 13.0%
128 () Aggrenox Boehringer Ingelheim Pharmaceuticals, Inc. 256,362 4.2%
129 (9) Lumigan Actavis Pharma, Inc. 255,177 7.0%
130 (5) Coreg CR GlaxoSmithKline 253,377 -4.7%
131 (14) Allegra-D 12 Hour Sanofi 252,670 -12.3%
132 (22) Welchol Daiichi Sankyo 252,474 20.6%
133 (2) Levitra Bayer HealthCare Pharmaceuticals Inc. 252,148 5.1%
134 Kadian Actavis Pharma, Inc. 250,497 2.5%
135 (32) Ortho Tri-Cyclen Lo Janssen Pharmaceuticals, Inc. 250,337 -28.6%
136 (5) Xeloda Genentech, Inc. 246,919 4.5%
137 () Toprol XL AstraZeneca 242,561 71.0%
138 (10) Maxalt Merck 240,341 9.9%
139 (20) Nasacort AQ Sanofi 239,549 -16.1%
140 (10) Zyvox Pfizer Inc. 238,542 -4.5%
141 (54) Opana ER Endo Pharmaceuticals Inc. 235,624 51.4%
142 (24) Procrit Janssen Biotech, Inc. 233,804 -18.8%
143 (12) Tussionex Sanofi 232,821 -5.6%
144 (87) Wellbutrin XL Bausch Health Companies Inc. 231,227 -62.3%
145 () Exforge Novartis Pharmaceuticals Corporation 228,459 53.4%
146 (10) Differin Galderma Laboratories, L.P. 227,198 -5.2%
147 () Humalog Mix 75/25 Pen Eli Lilly and Company 226,135 -0.4%
148 (27) Combivir GlaxoSmithKline 225,097 -18.4%
149 (3) Vigamox Alcon 224,627 1.8%
150 (6) Viread Gilead Sciences, Inc. 223,915 7.9%
151 () Trilipix Abbott Laboratories 221,001 NA
152 (3) Ciprodex Otic Alcon 218,781 5.3%
153 (104) Actonel 150 Actavis Pharma, Inc. 210,266 339.3%
154 () Maxalt MLT Merck 210,049 9.2%
155 (27) Duragesic Janssen Pharmaceuticals, Inc. 209,926 -16.6%
156 (14) Asmanex Merck 206,633 11.5%
157 (6) Relpax Pfizer Inc. 204,273 -4.2%
158 () Entocort EC AstraZeneca 200,489 55.0%
159 (14) BenzaClin Sanofi 198,107 -12.3%
160 (22) Micardis Boehringer Ingelheim Pharmaceuticals, Inc. 197,550 19.0%
161 (15) Enablex Actavis Pharma, Inc. 197,312 11.9%
162 (11) Micardis HCT Abbott Laboratories 197,278 9.4%
163 () Prezista Janssen Biotech, Inc. 191,366 48.1%
164 (2) Revlimid Bristol-Myers Squibb Company 190,965 -1.8%
165 () Travatan Z Alcon 190,516 56.9%
166 (15) Amitiza Takeda Pharmaceuticals U.S.A., Inc. 190,101 12.1%
167 (7) Alphagan P Actavis Pharma, Inc. 188,803 -3.6%
168 (1) Pegasys Genentech, Inc. 188,536 0.3%
169 (17) Patanol Alcon 187,599 -11.3%
170 () Xyzal Sanofi 187,542 30.0%
171 (2) Fentora Cephalon, Inc. 185,528 0.2%
172 (15) Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc. 184,799 -9.7%
173 (31) Clarinex Merck 181,215 -22.4%
174 (11) Avandamet GlaxoSmithKline 178,188 -7.6%
175 (38) Astelin Meda U.S. 177,778 -25.7%
176 (8) Ultram ER Janssen Pharmaceuticals, Inc. 174,664 -5.7%
177 (6) Zovirax topical GlaxoSmithKline 174,423 5.7%
178 (10) Valcyte Genentech, Inc. 174,413 8.6%
179 () Uroxatral Concordia Pharmaceuticals Inc. 174,034 21.6%
180 () Lialda Takeda Pharmaceuticals U.S.A., Inc. 173,802 54.6%
181 (9) Temodar Merck 172,475 -5.8%
182 () Pentasa Sanofi 171,083 17.0%
183 (11) Allegra-D 24 Hour Sanofi 167,692 7.2%
184 (1) Propecia Merck 166,878 2.3%
185 () Vivelle-DOT Novartis Pharmaceuticals Corporation 165,828 10.9%
186 () Zegerid Salix Pharmaceuticals, Inc. 164,756 17.7%
187 () Premarin Vaginal Pfizer Inc. 164,568 10.0%
188 () Exelon Patch Novartis Pharmaceuticals Corporation 162,259 74.4%
189 (9) Prempro Pfizer Inc. 161,662 5.9%
190 () Prandin Novo Nordisk 161,651 10.4%
191 (156) Imitrex Oral GlaxoSmithKline 161,167 -83.4%
192 Veramyst GlaxoSmithKline 160,387 1.3%
193 (7) Taclonex Warner Chilcott 159,082 -1.6%
194 (6) Xopenex HFA Sepracor Inc. 157,588 3.7%
195 () Duac Care System GlaxoSmithKline 155,643 9.3%
196 (7) Klor-Con Sandoz Inc. 153,842 -3.6%
197 () Epipen King Pharmaceuticals, Inc. 153,802 18.4%
198 (5) Avinza King Pharmaceuticals, Inc. 153,393 -2.4%
199 (9) Atacand AstraZeneca 152,603 -4.4%
200 () Elmiron Bayer HealthCare Pharmaceuticals Inc. 150,961 10.0%

Source: Verispan, VONA

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012